drugset / Trial / NCT03081039

A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma

NCT03081039 ↗

Phase 3 Withdrawn University of Louisville
RandomizedParallel-groupOpen-labelTreatment

Summary

Compare the efficacy of adjuvant chemotherapy with Cisplatin or Carboplatin and Gemcitabine versus Gemcitabine in patients with resected or ablated intra-hepatic cholangiocarcinoma.

Timeline

Start
2017-08-21
Primary completion
2022-04-28
Completion
2022-12-31

Outcome

Outcome not reported

Stopped: “Competing study”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carboplatin Small molecule — —
Comparator Cisplatin Other / unclassified — —
Comparator Gemcitabine Small molecule — —